PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL

Treatment of arterial hypertension (AH) despite the large variety of antihypertensive drugs currently remains one of the most urgent problems in modern cardiology. However, the scheme used in clinical practice does not always correspond to existing recommendations, in particular, of the European Soc...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
Μορφή:	Άρθρο
Γλώσσα:	Russian
Έκδοση:	Remedium Group LLC 2017-11-01
Σειρά:	Медицинский совет
Θέματα:	arterial hypertension cardiovascular complications antihypertensive therapy angiotensin converting enzyme inhibitors renin-angiotensin-aldosterone system blockers slow calcium channel blockers
Διαθέσιμο Online:	https://www.med-sovet.pro/jour/article/view/2007

Παρόμοια τεκμήρια

Influence of Antihypertensive Treatment on RAAS Peptides in Newly Diagnosed Hypertensive Patients
ανά: Annina S. Vischer, κ.ά.
Έκδοση: (2021-03-01)

Role of antihypertensive medicines in prostate cancer: a systematic review
ανά: Chinonyerem O. Iheanacho, κ.ά.
Έκδοση: (2024-04-01)

Blood Pressure Control and Antihypertensive Treatment among Hemodialysis Patients—Retrospective Single Center Experience
ανά: Piotr Skonieczny, κ.ά.
Έκδοση: (2021-06-01)

Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies
ανά: Yang Zhao, κ.ά.
Έκδοση: (2018-01-01)

The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism
ανά: Piotr Jędrusik, κ.ά.
Έκδοση: (2021-05-01)

Mechanisms of food protein-derived antihypertensive peptides other than ACE inhibition
ανά: Chibuike C. Udenigwe, κ.ά.
Έκδοση: (2014-05-01)

Prescription pattern and effectiveness of antihypertensive drugs in patients with aortic dissection who underwent surgery
ανά: Kuang-Ming Liao, κ.ά.
Έκδοση: (2023-11-01)

Renin-angiotensin-aldosterone system blockers as the main pathogenetic approach of drug nephroprotection
ανά: N.D. Filipets, κ.ά.
Έκδοση: (2019-02-01)

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research
ανά: Jordan Loader, κ.ά.
Έκδοση: (2022-06-01)

Controversial Roles of the Renin Angiotensin System and Its Modulators During the COVID-19 Pandemic
ανά: Simon B. Gressens, κ.ά.
Έκδοση: (2021-02-01)

Renin-angiotensin system blockers and COVID-19
ανά: Emmanuelle Vidal-Petiot, κ.ά.
Έκδοση: (2021-06-01)

Angiotensins and rheumatoid arthritis
ανά: N. M. Savushkina, κ.ά.
Έκδοση: (2019-01-01)

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study
ανά: José Luño, κ.ά.
Έκδοση: (2017-07-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
ανά: JungMin Choi, κ.ά.
Έκδοση: (2024-05-01)

Association of Cardiovascular Medications With Adverse Outcomes in a Matched Analysis of a National Cohort of Patients With COVID-19
ανά: Leonard K. Wang, κ.ά.
Έκδοση: (2023-06-01)

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement
ανά: Fabrizio Buffolo, κ.ά.
Έκδοση: (2021-05-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
ανά: N. V. Drobotya, κ.ά.
Έκδοση: (2020-06-01)

Effect of different single and combined antihypertensive drug regimens on the mortality of critical care patients
ανά: Yipeng Fang, κ.ά.
Έκδοση: (2024-08-01)

Treatment of proteinuria in dogs with telmisartan: A retrospective study
ανά: Julie Lecavalier, κ.ά.
Έκδοση: (2021-07-01)

Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study
ανά: Jenny I. Shen, κ.ά.
Έκδοση: (2017-06-01)

Research Progress on Antihypertensive Effect of Polysaccharide and Its Mechanism
ανά: Jilong XU, κ.ά.
Έκδοση: (2023-02-01)

Antihypertensive therapy in patients with arterial hypertension and concomitant diseases in real clinical practice (according to the National Registry of Arterial Hypertension, 2019–2022)
ανά: Anna V. Aksenova, κ.ά.
Έκδοση: (2024-10-01)

INACTIVATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM. WHICH CLASS OF ANTIHYPERTENSIVE MEDICINE PRODUCTS TO PREFER?
ανά: S. V. Stolov
Έκδοση: (2020-12-01)

Effect of antihypertensive treatment on the long-term outcome of patients discharged after acute ischemic stroke
ανά: Konstantinos Tziomalos, κ.ά.
Έκδοση: (2017-04-01)

Sartans in the treatment of high-risk hypertension: the abilities of candesartan
ανά: T E Morozova
Έκδοση: (2013-06-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
ανά: K. A. Ghyamdzhyan, κ.ά.
Έκδοση: (2022-12-01)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
ανά: Stine Andersen, κ.ά.
Έκδοση: (2016-06-01)

Effect of ACEi and ARBs vs Non ACEi/ARBs in Hypertension with Respect to Renal Outcomes in COVID-19 Infection: A Retrospective Cohort Study
ανά: S Ravitej, κ.ά.
Έκδοση: (2022-11-01)

Assessment of optimal renin-angiotensin-system inhibition strategy in Asian patients with STEMI after primary myocardial revascularization
ανά: Hye-Jin Park, κ.ά.
Έκδοση: (2022-01-01)

Perspectives of using angiotensin receptor antagonists
ανά: V V Fomin
Έκδοση: (2009-06-01)

Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network
ανά: Steven M. Smith, κ.ά.
Έκδοση: (2023-01-01)

Hypertension, medications, and risk of severe COVID‐19: A Massachusetts community‐based observational study
ανά: Ann Z. Bauer, κ.ά.
Έκδοση: (2021-01-01)

A high sodium intake reduces antiproteinuric response to renin–angiotensin–aldosterone system blockade in kidney transplant recipients
ανά: Elena Monfá, κ.ά.
Έκδοση: (2016-09-01)

Early Rapid Decline in Kidney Function as a Beneficial Sign After Starting Antihypertensive Medication
ανά: Joachim Beige
Έκδοση: (2019-06-01)

The Use of Antihypertensive Drugs as Coadjuvant Therapy in Cancer
ανά: José A. Carlos-Escalante, κ.ά.
Έκδοση: (2021-05-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
ανά: Maksimov M.L., κ.ά.
Έκδοση: (2017-02-01)

Angiotensin receptor blocker telmisartan: efficacy, safety and relevance of clinical application
ανά: M L Maksimov, κ.ά.
Έκδοση: (2017-03-01)

Clinical pharmacogenetics of angiotensin II receptor blockers in Iraq
ανά: Hany A Al-Hussaniy, κ.ά.
Έκδοση: (2023-01-01)

A Study of Morphological Changes in Renal Afferent Arterioles Induced by Angiotensin II Type 1 Receptor Blockers in Hypertensive Patients
ανά: Yohko Nagai, κ.ά.
Έκδοση: (2020-01-01)

Capacities of laboratory diagnosis in the assessment of the activity of the renin-angiotensin-aldosterone system
ανά: M L Maksimov
Έκδοση: (2010-06-01)